Abstract
Since its first reported use for the treatment of burns victims, acellular dermal matrix (ADM) use has expanded to surgeries including repairing thoracic and abdominal wall defects, and breast reconstruction. FlexHD® is a brand of ADM prepared from human cadaveric dermis that has been processed to remove antigenic components and is used to reinforce the subpectoral pocket created during submuscular breast implant surgery. Recent documentation of a phenomenon termed ‘red breast syndrome’ (RBS) has emerged in the medical literature, with little known about its aetiology and treatment. This paper presents a case of blistering cutaneous erythema from FlexHD® ADM.
Highlights
Since its first reported use for the treatment of burns victims, acellular dermal matrix (ADM) use has expanded to surgeries including repairing thoracic and abdominal wall defects, and breast reconstruction
FlexHD® (125 May St, Edison, NJ 08837, United States) is a brand of ADM prepared from human cadaveric dermis that has been processed to remove antigenic components and is used to reinforce the subpectoral pocket created during submuscular breast implant surgery
This paper presents a case of blistering cutaneous erythema from FlexHD® ADM, reviews the current literature on red breast syndrome’ (RBS) and proposes a treatment methodology
Summary
The aetiology, risk factors and treatment of RBS red breast syndrome are elusive. While the presentations of RBS can be varied, the current literature, as well as our case, demonstrate that RBS is primarily characterised by a cutaneous erythema over the region of an inserted ADM. The presence or absence of systemic symptoms should not be the primary determining factor in stratifying RBS from infection, but rather the presence or absence of stable erythema. Further recognition and study of this condition is required to determine cause and appropriate treatment. Consent to publish Patients signed informed consent regarding publishing their data and photographs. Disclosure The authors have no conflicts of interest to disclose. Funding The authors received no financial support for the research, authorship, and/or publication of this article
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
